NCT05120947View on ClinicalTrials.gov

Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers

NAActive, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

March 6, 2025

Study Completion Date

November 18, 2025

Conditions
Resectable Head and Neck Squamous Cell Carcinoma
Interventions
RADIATION

42 Gy Radiation Therapy

Radiation Therapy: Dose per fraction of 4.2 Gy.

RADIATION

39 Gy Radiation Therapy

Radiation Therapy: Dose per fraction of 4.875 Gy.

RADIATION

32.5 Gy Radiation Therapy

Radiation Therapy: Dose per fraction of 6.5 Gy.

Trial Locations (1)

53226

Froedtert & the Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER